Showing results (511-520 of 582) with videos related to
Sort By:
Pageof 59
JCI Insight|January 25, 2019
Adaptive NK cell reconstitution is associated with better clinical outcomesFrank Cichocki, Emily Taras, Flavia Chiuppesi, et al.Radiology|May 1, 1983
Peripheral hepatic artery embolization for primary and secondary hepatic neoplasmsM E Clouse, R G Lee, E J Duszlak, et al.World Neurosurgery|September 28, 2018
Intracranial Electrode Placement for Seizures Before Temporal Lobectomy: A Risk-Benefit AnalysisAbhiraj D Bhimani, Ashley N Selner, Darian R Esfahani, et al.Journal of Medicinal Chemistry|November 1, 1991
Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-on e (TIBO) derivatives. 2M J Kukla, H J Breslin, C J Diamond, et al.Human Pathology|December 4, 2003
Computerized diagnostic decision support system for the classification of preinvasive cervical squamous lesionsG J Price, W G McCluggage, M L Morrison M, et al.Bioorganic & Medicinal Chemistry Letters|June 15, 2012
Identification of a dual δ OR antagonist/μ OR agonist as a potential therapeutic for diarrhea-predominant Irritable Bowel Syndrome (IBS-d)Henry J Breslin, Craig J Diamond, Robert W Kavash, et al.Blood|April 17, 2009
Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipientsWendi Zhou, Jeff Longmate, Simon F Lacey, et al.Journal of Medicinal Chemistry|March 3, 1995
Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo-[4,5,1-jk][1,4]benzodiazepin- 2(1H)-one (TlBO) derivatives. 4W Ho, M J Kukla, H J Breslin, et al.Journal of Cancer Research and Clinical Oncology|May 18, 2007
Oblimersen and alpha-interferon in metastatic renal cancer: a phase II study of the California Cancer ConsortiumKim Margolin, Timothy W Synold, Primo Lara, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2009
The effect of single and combined activating killer immunoglobulin-like receptor genotypes on cytomegalovirus infection and immunity after hematopoietic cell transplantationJohn A Zaia, Joel Y Sun, Ghislaine M Gallez-Hawkins, et al.Pageof 59